About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Gait and REM Sleep Behavior Disorder | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNANCT02554331

Gait and REM Sleep Behavior Disorder

Many people with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD) have an underlying synucleinopathy, the most common of which are Parkinson's disease (PD) and Lewy body disease. Iden...

Lead sponsor: University Hospital, Montpellier•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Hospital, Montpellier

Collaborators

Université Montpellier

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria: * Specific inclusion criteria for RBD patients - to reach the diagnosis criteria of RBD (International Classification of Sleep Disorders 2) * Specific inclusion criteria for PD patients - to reach the diagnosis criteria of idiopathic PD (Queen Square Brain Bank) - Hoehn Yahr score ≤ 2 Exclusion Criteria: * Specific exclusion criteria for RBD patients - diagnosis of PD - other pathology associated to RBD diagnosis - presence of antiparkinsonism medication * Specific exclusion criteria for PD patients - clinical signs of parkinsonian syndrome- Mini Mental State Examination \< 24/30- gait disorder clinically observable * Specific exclusion criteria for controls - neurological disease- gait disorder

Related studies

Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease

NCT07398157 · PD - Parkinson's Disease

Neuroplasticity in RBD

NCT05471960 · REM Sleep Behavior Disorder

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

NCT07330258 · Parkinson's Disease

Blood Flow Restriction for Optimizing Balance in Parkinson's Disease

NCT06508801 · Parkinson's Disease and Parkinsonism

Implementing a National Biobank of PD With WGS and Functional Assessment of Polygenic Inheritance by iPSC Technology

NCT05721911 · Parkinson Disease, REM Sleep Behavior Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 23, 2021Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment63

Start dateApr 2014

Last updatedDec 23, 2021

Condition

Parkinson's Disease REM Sleep Behavior Disorder

Locations shown

University hospital

Montpellier

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 23, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions